Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: Results of the first prospective randomized phase II trial.

BACKGROUND: In nonrandomized trials, neoadjuvant treatment was reported to prolong survival in patients with pancreatic cancer. As neoadjuvant chemoradiation is established for the treatment of rectal cancer we examined the value of neoadjuvant chemoradiotherapy in pancreatic cancer in a randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Golcher, Henriette, Brunner, Thomas B., Witzigmann, Helmut, Marti, Lukas, Bechstein, Wolf-Otto, Bruns, Christiane, Jungnickel, Henry, Schreiber, Stefan, Grabenbauer, Gerhard G., Meyer, Thomas, Merkel, Susanne, Fietkau, Rainer, Hohenberger, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289008/
https://www.ncbi.nlm.nih.gov/pubmed/25252602
http://dx.doi.org/10.1007/s00066-014-0737-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289008/
https://www.ncbi.nlm.nih.gov/pubmed/25252602
http://dx.doi.org/10.1007/s00066-014-0737-7

Ejemplares similares